Abstract

Objective: To determine if intermittent magnesium sulfate infusion can safely be administered in the non-intensive care setting to decrease duration of continuous albuterol therapy, decrease overall length of stay and reduce the need for increased level of care (non-invasive respiratory support). Methods: We performed a retrospective cohort analysis of children age 2-18 years admitted to the inpatient, non-intensive care units on continuous albuterol for > 6 hours for the management of status …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call